U.S. Markets closed

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Board of Directors of Envision Healthcare, CoBiz, and Cotiviti on Behalf of Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Envision Healthcare Corporation, CoBiz Financial, Inc., and Cotiviti Holdings.  Additional information about each potential action can be found at the link provided.

Envision Healthcare Corporation (EVHC)

Buyer: Kohlberg Kravis Roberts & Co. (KKR)

Pursuant to the proposed transaction, announced on June 11, 2018 and valued at approximately $9.9 billion, Envision stockholders will receive $46.00 per share for each Envision share that they own.  Our investigation concerns whether Envision’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive agreement with KKR.

To learn more about the Envision investigation go to: http://bespc.com/envision/.

CoBiz Financial, Inc. (COBZ)

Buyer: BOK Financial Corporation. (BOKF)

Pursuant to the proposed transaction, announced on June 19, 2018 and valued at approximately $1 billion, CoBiz stockholders will receive $5.70 and 0.17 shares of BOK for each CoBiz common stock.  Our investigation concerns whether CoBiz’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive merger agreement with BOK.  

To learn more about the CoBiz investigation go to:  https://bespc.com/cobz/.

Cotiviti Holdings, Inc. (COTV)

Buyer: Verscend Technologies, Inc. (Verscend)

Pursuant to the proposed transaction, announced on June 19, 2018 and valued at approximately $4.9 billion, Cotiviti stockholders will receive $44.75 per share for each Cotiviti common stock.  Advent International, a private equity firm, has entered into a voting agreement whereby it will vote shares representing 44% of the Company’s voting power in favor of the transaction.  Our investigation concerns whether Cotiviti’s board of directors failed to adequately shop the company and obtain the best possible price for its stockholders before entering into a definitive merger agreement with Verscend.  

To learn more about the Cotiviti investigation go to: https://bespc.com/cotv/.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com.

Contacts

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 308-1869
investigations@bespc.com
www.bespc.com